Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Unexpected Infection Spikes in a Model of Respiratory Syncytial Virus Vaccination.

Smith RJ, Hogan AB, Mercer GN.

Vaccines (Basel). 2017 May 18;5(2). pii: E12. doi: 10.3390/vaccines5020012.

2.

Development of Electrochemiluminescent Serology Assays to Measure the Humoral Response to Antigens of Respiratory Syncytial Virus.

Maifeld SV, Ro B, Mok H, Chu M, Yu L, Yamagata R, Leonardson T, Chio V, Parhy B, Park S, Carlson M, Machhi S, Ulbrandt N, Falsey AR, Walsh EE, Wang CK, Esser MT, Zuo F.

PLoS One. 2016 Apr 12;11(4):e0153019. doi: 10.1371/journal.pone.0153019. eCollection 2016.

3.

Burden of Influenza and Respiratory Syncytial Virus Infection in Pregnant Women and Infants Under 6 Months in Mongolia: A Prospective Cohort Study.

Chaw L, Kamigaki T, Burmaa A, Urtnasan C, Od I, Nyamaa G, Nymadawa P, Oshitani H.

PLoS One. 2016 Feb 5;11(2):e0148421. doi: 10.1371/journal.pone.0148421. eCollection 2016.

4.

The transfer and decay of maternal antibody against Shigella sonnei in a longitudinal cohort of Vietnamese infants.

Thompson CN, Le TP, Anders KL, Nguyen TH, Lu LV, Nguyen VV, Vu TD, Nguyen NM, Tran TH, Ha TT, Tran VT, Pham VM, Tran do HN, Le TQ, Saul A, Martin LB, Podda A, Gerke C, Thwaites G, Simmons CP, Baker S.

Vaccine. 2016 Feb 3;34(6):783-90. doi: 10.1016/j.vaccine.2015.12.047. Epub 2015 Dec 29.

5.

Maternal transfer of RSV immunity in cotton rats vaccinated during pregnancy.

Blanco JC, Pletneva LM, Oue RO, Patel MC, Boukhvalova MS.

Vaccine. 2015 Oct 5;33(41):5371-9. doi: 10.1016/j.vaccine.2015.08.071. Epub 2015 Aug 31.

6.

Quantifying maternally derived respiratory syncytial virus specific neutralising antibodies in a birth cohort from coastal Kenya.

Nyiro JU, Sande C, Mutunga M, Kiyuka PK, Munywoki PK, Scott JA, Nokes DJ.

Vaccine. 2015 Apr 8;33(15):1797-801. doi: 10.1016/j.vaccine.2015.02.039. Epub 2015 Feb 26.

7.

Vaccines against respiratory viral pathogens for use in neonates: opportunities and challenges.

Alexander-Miller MA.

J Immunol. 2014 Dec 1;193(11):5363-9. doi: 10.4049/jimmunol.1401410. Review.

8.

Immunity to RSV in Early-Life.

Lambert L, Sagfors AM, Openshaw PJ, Culley FJ.

Front Immunol. 2014 Sep 29;5:466. doi: 10.3389/fimmu.2014.00466. eCollection 2014. Review.

9.

Protection and mechanism of action of a novel human respiratory syncytial virus vaccine candidate based on the extracellular domain of small hydrophobic protein.

Schepens B, Sedeyn K, Vande Ginste L, De Baets S, Schotsaert M, Roose K, Houspie L, Van Ranst M, Gilbert B, van Rooijen N, Fiers W, Piedra P, Saelens X.

EMBO Mol Med. 2014 Nov;6(11):1436-54. doi: 10.15252/emmm.201404005.

10.

The association between age and the development of respiratory syncytial virus neutralising antibody responses following natural infection in infants.

Sande CJ, Cane PA, Nokes DJ.

Vaccine. 2014 Aug 20;32(37):4726-9. doi: 10.1016/j.vaccine.2014.05.038. Epub 2014 Jul 6.

11.

Respiratory syncytial virus transplacental antibody transfer and kinetics in mother-infant pairs in Bangladesh.

Chu HY, Steinhoff MC, Magaret A, Zaman K, Roy E, Langdon G, Formica MA, Walsh EE, Englund JA.

J Infect Dis. 2014 Nov 15;210(10):1582-9. doi: 10.1093/infdis/jiu316. Epub 2014 Jun 5.

12.

Sendai virus-based RSV vaccine protects against RSV challenge in an in vivo maternal antibody model.

Jones BG, Sealy RE, Surman SL, Portner A, Russell CJ, Slobod KS, Dormitzer PR, DeVincenzo J, Hurwitz JL.

Vaccine. 2014 May 30;32(26):3264-73. doi: 10.1016/j.vaccine.2014.03.088. Epub 2014 Apr 14.

13.

Fc gamma receptors in respiratory syncytial virus infections: implications for innate immunity.

Jans J, Vissers M, Heldens JG, de Jonge MI, Levy O, Ferwerda G.

Rev Med Virol. 2014 Jan;24(1):55-70. doi: 10.1002/rmv.1773. Epub 2013 Nov 14. Review.

14.

Cellular and humoral immunity of virus-induced asthma.

Okayama Y.

Front Microbiol. 2013 Aug 27;4:252. doi: 10.3389/fmicb.2013.00252. eCollection 2013.

15.

Intranasal administration of antibody-bound respiratory syncytial virus particles efficiently primes virus-specific immune responses in mice.

Kruijsen D, Einarsdottir HK, Schijf MA, Coenjaerts FE, van der Schoot EC, Vidarsson G, van Bleek GM.

J Virol. 2013 Jul;87(13):7550-7. doi: 10.1128/JVI.00493-13. Epub 2013 May 1.

16.

Neonatal antibody responses are attenuated by interferon-γ produced by NK and T cells during RSV infection.

Tregoning JS, Wang BL, McDonald JU, Yamaguchi Y, Harker JA, Goritzka M, Johansson C, Bukreyev A, Collins PL, Openshaw PJ.

Proc Natl Acad Sci U S A. 2013 Apr 2;110(14):5576-81. doi: 10.1073/pnas.1214247110. Epub 2013 Mar 18.

17.

Reversion of somatic mutations of the respiratory syncytial virus-specific human monoclonal antibody Fab19 reveal a direct relationship between association rate and neutralizing potency.

Bates JT, Keefer CJ, Utley TJ, Correia BE, Schief WR, Crowe JE Jr.

J Immunol. 2013 Apr 1;190(7):3732-9. doi: 10.4049/jimmunol.1202964. Epub 2013 Mar 1.

18.

Vaccination against RSV: is maternal vaccination a good alternative to other approaches?

Kaaijk P, Luytjes W, Rots NY.

Hum Vaccin Immunother. 2013 Jun;9(6):1263-7. doi: 10.4161/hv.24096. Epub 2013 Feb 26.

19.

Molecular epidemiology and disease severity of human respiratory syncytial virus in Vietnam.

Tran DN, Pham TM, Ha MT, Tran TT, Dang TK, Yoshida LM, Okitsu S, Hayakawa S, Mizuguchi M, Ushijima H.

PLoS One. 2013;8(1):e45436. doi: 10.1371/journal.pone.0045436. Epub 2013 Jan 22.

20.

The natural history of respiratory syncytial virus in a birth cohort: the influence of age and previous infection on reinfection and disease.

Ohuma EO, Okiro EA, Ochola R, Sande CJ, Cane PA, Medley GF, Bottomley C, Nokes DJ.

Am J Epidemiol. 2012 Nov 1;176(9):794-802. doi: 10.1093/aje/kws257. Epub 2012 Oct 11.

Supplemental Content

Support Center